Back to Business

Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock

Business November 1, 2026 at 6:31 AM

Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock

Investing.com

Read the full story at Investing.com

More Stories

Iran offers 48-hour Hormuz reopening plan as Trump signals progress in talks

Iran offers 48-hour Hormuz reopening plan as Trump signals progress in talks

🇺🇸 Investing.com 39m ago

Bitcoin tests 38.2% Fib after triangle breakdown: Live levels

Bitcoin tests 38.2% Fib after triangle breakdown: Live levels

🇺🇸 Investing.com 56m ago

Bangladesh forms wage board as garment protests turn violent

Bangladesh forms wage board as garment protests turn violent

🇺🇸 Investing.com 58m ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play